This website uses technical, analytics and third party cookies.
By continuing to browse, you accept our cookies.

Privacy policy

  • Go to content
  • Browse the site
Menu
Italian Medicines Agency

Italian Medicines Agency

Follow us on

  • Facebook
  • Twitter
  • Youtube

Language Selector

  • ITA
  • ENG
 
 
 

label.navivation.menu

  • The Agency
    • The Agency
    • Mission and values
    • Organisation
    • Technical and advisory committees
    • Support and Coordination Secretariats and Advisory Committees
    • International Collaborations
    • Legislation
    • Forms
    • Competition notices
    • Resolutions
    • Tenders and contracts
    • Quality assurance
    • Guarantee Committee
    • Open AIFA
    • Contacts
    • Certified email
  • COVID-19 Emergency
    • COVID-19 Emergency
    • COVID-19 Vaccines
    • Medicines usable for treatment of COVID-19 disease
    • Monitoring of medicinal products used during the COVID-19 epidemic
    • Recommendations on use of medicines in the population exposed to the virus
    • Clinical Trials - COVID-19
    • Compassionate Use Programs - COVID-19
    • COVID-19 Emergency Donations
    • Authorised import procedures - COVID-19 Emergency 
  • Access to medicinal products
    • Access to medicinal products
    • Early access and off-label use
    • Authorisation of medicinal products
    • Medicine shortages
    • Antibiotic medicinal products
    • Biological medicinal products
    • Vaccines
    • Blood derivatives
    • Generic medicinal products
    • Biosimilar medicinal products
    • Orphan medicinal products
    • Advanced therapies
    • Homeopathic medicinal products
    • Allergens
  • Safety of medicinal products
    • Safety of medicinal products
    • Pharmacovigilance 
    • National Pharmacovigilance Network
    • The RAM System
    • Persons in charge of Pharmacovigilance
    • European Eudravigilance System
    • Adverse Reactions to medicinal products
    • Regional pharmacovigilance funds
    • Pharmacovigilance signals
    • PSURs (Periodic safety update reports)
    • Risk management measures
    • Medicinal products subject to additional monitoring
  • Quality and Inspections
    • Quality and Inspections
    • Quality defects
    • Inspections and authorisations
    • Qualified person
    • Fight of pharmaceutical crime
  • Research and Clinical trials
    • Research and Clinical trials
    • Clinical trials concerning medicinal products
    • National Observatory on Clinical Trials
    • Ethical Committees Coordination Centre
    • Independent clinical research
  • Pricing and reimbursement
    • Pricing and reimbursement
    • Negotiation and reimbursement
    • Economic evaluations
    • Monitoring Registers
    • AIFA Notes
    • Lists of Class A and Class H medicinal products
    • Innovative medicinal products
    • Transparency Lists
  • Consumption and pharmaceutical expenditure
    • Consumption and pharmaceutical expenditure
    • The Medicines Utilization Monitoring Centre (OsMed) 
    • Governance of pharmaceutical expenditure
    • Monitoring pharmaceutical expenditure
  • Innovation and planning
    • Innovation and planning
    • Innovation and scientific advice
    • Horizon scanning
  • Information and communication
    • Information and communication
    • FarmaciLine
    • Medical and scientific information
    • Questions and answers
    • Publications
    • AIFA editorials
    • Public consultations
    • Documents shared with scientific communities 
    • World news
    • Communication campaigns
    • Press corner
    • Archive
  • AIFA data
    • AIFA data
    • OsMed Data
    • Open Data
  • Administrative services
    • Administrative services
    • Requests for authorisation of conferences and meetings
    • Service of administrative documents
    • Payment of fees and annual duties
    • MA Electronic invoicing
  • Open governance
    • Open governance
    • Disposizioni Generali
    • Organizzazione
    • Consulenti e collaboratori
    • Personale
    • Bandi di Concorso
    • Performance
    • Enti controllati
    • Attività e procedimenti
    • Provvedimenti
    • Bandi di gara e contratti
    • Sovvenzioni, contributi, sussidi, vantaggi economici
    • Bilanci
    • Beni immobili e gestione patrimonio
    • Controlli e rilievi sull'Amministrazione
    • Servizi Erogati
    • Pagamenti dell'Amministrazione
    • Opere pubbliche
    • Pianificazione e governo del territorio
    • Informazioni ambientali
    • Interventi straordinari di emergenza
    • Altri Contenuti
Italian Medicines Agency Agenzia Italiana del Farmaco

Forms

Breadcrumb

  • Home
  • The Agency
  • Forms

Forms – Obligatory information for citizens and companies

This page contains the links to access the obligatory information for citizens and companies within the AIFA Portal, pursuant to Art. 34 of Legislative Decree 33/2013.

Site Map

  • AIFA guidelines
  • Interaction with AIFA IT infrastructure
  • Accreditation of representatives
  • Forms for reporting adverse reactions
  • Forms for shortages
  • Forms for quality defects
  • Clinical trials
  • GMP forms - Medicinal products
  • GMP forms - Raw materials
  • Forms for Certifications and Parallel imports
  • Reporting of medicinal products thefts
  • Communication to Collegiate Bodies Secretariat
  • Payment of fees and annual duties
  • Direct communication to OIV

Miscellaneous forms

PDF Documents to be attached to the renewal application [0.13 Mb] >

ODT Request for access to administrative documents [0.05 Mb] >

PDF Request form of an Innovation Meeting [0.11 Mb] >

PDF Guideline on use of electronic signature verification tools [0.59 Mb] >

Applications submitted to AIFA electronically: methods for paying stamp duty

PDF Methods of payment of stamp duty for applications [0.22 Mb] >

PDF Self-certification form for paper stamp duty [0.09 Mb] >

Site Map

The Agency

  • Mission and values
  • Organisation
  • Technical and advisory committees
  • Support and Coordination Secretariats and Advisory Committees
  • International Collaborations
  • Legislation
  • Forms
    • AIFA guidelines
    • Interaction with AIFA IT infrastructure
    • Accreditation of representatives
    • Forms for reporting adverse reactions
    • Forms for shortages
    • Forms for quality defects
    • Clinical trials
    • GMP forms - Medicinal products
    • GMP forms - Raw materials
    • Forms for Certifications and Parallel imports
    • Reporting of medicinal products thefts
    • Communication to Collegiate Bodies Secretariat
    • Payment of fees and annual duties
    • Direct communication to OIV
  • Competition notices
  • Resolutions
  • Tenders and contracts
  • Quality assurance
  • Guarantee Committee
  • Open AIFA
  • Contacts
  • Certified email

Share

The Agency

  • Home Page >
  • Farmaciline >
  • User participation and satisfaction >
  • Citizens' access >
  • Open governance >

Contacts

  • Via del Tritone, 181
    00187 Rome
  • Contacts >
  • Certified e-mail (PEC) contacts >
  • VAT number: 08703841000
    Tax code: 97345810580
    IPA code: UFE1TR

Follow us on

  • Facebook
  • Twitter
  • Youtube
  • Legal notice
  • Sitemap
  • Web accessibility
  • Website statistics
  • Privacy
  • Online services
  • Intranet
go to beginning of content